insitro Stock
HealthTechLooking to sell insitro stock or options?
Insitro is a leader in the field of data-driven drug discovery and development, aiming to revolutionize the way drugs are discovered and supplied to patients. By employing machine learning and high-throughput biology, insitro generates vast data sets that tackle major obstacles in pharmaceutical R&D. This enables pharmaceutical companies to utilize predictive models that hasten the process of target selection, therapeutic design and development, and the formulation of clinical strategies.
Foresite Capital, BlackRock, SoftBank Investment Advisers, HOF Capital, Andreessen Horowitz, TLI Bedrock, Bezos Expeditions, T. Rowe Price Group, GV, Alexandria Venture Investments, Two Sigma Ventures, A&E Investments, HBM Genomics, Mubadala Capital, Temasek Holdings, Verily Life Sciences, RONA Holdings, Third Rock Ventures, Globalive Capital, WuXi AppTec, ADS Ventures, CPP Investments, Casdin Capital, ARCH Venture Partners.